about
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyPsoriasis and comorbid diseases: Epidemiology.Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literature.Total homocysteine and cardiovascular disease.Psoriasis and hypertension severity: results from a case-control study.Infection and inflammation-induced proatherogenic changes of lipoproteins.Is renal function altered in patients with psoriasis vulgaris?--A short review.12-lipoxygenase: a potential target for novel anti-platelet therapeutics.Update of the management of chronic psoriasis: new approaches and emerging treatment options.Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides.Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literatureThe importance of disease associations and concomitant therapy for the long-term management of psoriasis patientsNon-alcoholic fatty liver disease and psoriasis: So far, so near.A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis.Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study.The comorbid state of psoriasis patients in a university dermatology practice.Risk and predictors of cardiovascular disease in psoriasis: a population-based study.Psoriasis: it's more than just the skin.Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.Metabolic syndrome and skin: psoriasis and beyond.Psoriasis comorbidities.Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center.Platelet function in cutaneous diseases.Psoriasis comorbidities.Relationship between tumor necrosis factor-α inhibitors and cardiovascular disease in psoriasis: a review.Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis.Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms.Cardiovascular aspects of psoriasis: an updated review.IL-17 targeted therapies for psoriasis.Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease.The effect of tumour necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: A retrospective study.Heart rate recovery is impaired in patients with psoriasisPlasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.Pathologic findings in internal organs in psoriasis.Influence of psoriasis on circulatory system function assessed in echocardiography.Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.Association of chronic plaque psoriasis and severe periodontitis: a hospital based case-control study.Renal abnormalities in a population of patients with psoriatic arthritis.Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis.
P2860
Q21135505-D3DD464F-6AA4-4F26-A258-732281DDD6F0Q30235889-2C52D61C-1800-4CAB-92AA-AE544E9C532AQ33548150-B759B7CA-3B79-4741-9951-0A9DD0A209B8Q33785883-18E4C455-7CE6-4721-83EB-8B6234C4692AQ33867611-3E157A1C-7734-427D-AA53-66FD7E30E7E9Q33935040-6791B85E-A6C8-439D-BE11-0059E0514CFBQ34070923-36B1FAE7-E8AB-4306-9DB5-BFA1DE1777B9Q34207687-FBC6701C-DCA4-41E3-BECB-5EABFF75E989Q34620375-63F365E4-2D89-49CB-B665-507646CDE033Q35070294-EE47CCAF-5AAA-4A8C-A8D2-07E34B23F354Q35168945-816939B2-9668-4D72-9319-DA534C152C27Q35230117-FCB63E9D-3544-47C2-85B3-1CDB83A196F6Q35237307-5864808C-ECE2-4CE5-8C12-3C5555AAE160Q35564628-0747DC84-C83F-4A2E-817D-3C9A31DE2239Q35854188-75B5A958-4736-4576-98DA-20C60DC74CFAQ36374594-0534101C-6549-40C5-8123-0219F49CFBBEQ36515160-0A23F694-BEDD-41A9-BAA5-383B3016FE38Q36520300-9E811A53-4387-4E4E-8C7A-20C14EEAA4B3Q36879686-31A350F3-3FEC-4267-80D2-B3C941C78091Q37054329-C968E5C4-CE64-4FDF-956F-122A2462830BQ37084274-569A4141-72A4-482A-9923-7A933D61887EQ37118037-1D8303EC-3C1D-47B8-803A-2694C5EAFB74Q37268952-3E1F7CE9-D46D-4DF6-9B66-D6DBDCD02587Q37607422-FD926AB1-9ADB-444F-9E27-B154BCE18236Q37632485-EDFA6692-906A-4CC0-8DDC-D480A6E311C6Q37693885-A09BE592-0595-481C-8E22-773907BB8DADQ37903373-49D96749-2992-4BED-AB79-BD9B9A8D201DQ38076496-7F60F67D-E4E8-4587-8593-9DE3541F35FAQ38111443-9BEAE8AE-B3EA-4F7C-86B5-9C3BD917C23CQ39117416-13209F00-035A-4746-BFB0-1F532AA19D50Q39158398-367714E0-D5A3-48AF-9FAB-FE0AE0DE14B7Q39375369-60EC3F14-1F8F-4AFB-B5AC-EAABB6512E55Q40083837-D7A6D481-2DE1-481F-ABFD-7E15196D4856Q40677360-D5D8096F-D159-4A0D-BCB2-F6E5D546A341Q41631142-9BC019CF-D2DA-4F78-8FBA-F63CE578A9ECQ43477625-19109AEC-8F0A-4E39-BA58-E9FBF72374A4Q43481799-0CDE3ED5-00F7-4FEE-8162-AEB9F2098345Q43811785-8EEDE32B-30C8-45E7-9CEC-A960B24281D8Q44859412-802740E8-216C-401C-AD3E-DF0DBEA7BC10Q46977851-44E5E9C3-4965-45C6-940C-B0E9AE8F7992
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Psoriasis and occlusive vascular disease.
@en
type
label
Psoriasis and occlusive vascular disease.
@en
prefLabel
Psoriasis and occlusive vascular disease.
@en
P2860
P1476
Psoriasis and occlusive vascular disease.
@en
P2093
Calabresi P
McDonald CJ
P2860
P304
P356
10.1111/J.1365-2133.1978.TB02012.X
P407
P577
1978-11-01T00:00:00Z